Keywords: BioInvent, Servier, Oncology collaboration, Tumor cell metabolism

BioInvent and Servier ink oncology collaboration

Article | 05 January 2012

Sweden’s BioInvent International (OMXS: BINV) and independent French drugmaker Laboratoires Servier have entered into an antibody collaboration on ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Servier

BioInvent

Go to company listing